ArticleOncology letters2026
High-intensity focused ultrasound in the multimodal treatment of colorectal cancer liver metastases: A case report.
Article in Oncology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colorectal liver metastasis (CRLM) is typically associated with a poor prognosis. However, adopting multiple comprehensive treatment methods can significantly improve patients' long-term survival rates. High-intensity focused ultrasound (HIFU) is an emerging therapeutic technique that presents new treatment possibilities for patients. The present study reports the case of a patient who was diagnosed with liver metastasis following laparoscopic rectal cancer surgery. After unsuccessful tumor control with classical chemotherapy, radiofrequency ablation and interventional embolization therapy, the patient underwent HIFU treatment, which resulted in complete tumor remission and >10 years of tumor-free survival. In this case, HIFU treatment significantly improved tumor control without causing additional trauma. This case highlights a successful multimodal treatment approach for CRLM and provides valuable insights for similar cases, underscoring the importance of personalized treatment that integrates multiple therapeutic modalities. As a non-invasive and innovative technique, HIFU demonstrates significant potential in providing a new avenue for the future treatment of CRLM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.